We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CYP market cap is 37.72M. The company's latest EPS is AUD -0.0795 and P/E is -2.64.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 66k | 0 | 0 | 0 |
| Operating Income | -8.69M | -3.14M | -7.49M | -6.07M | -14.89M |
| Net Income | -8.47M | -3.64M | -7.69M | -5.45M | -14.28M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 12.25M | 17.48M | 29.98M | 26.55M | 18.99M |
| Total Liabilities | 1.28M | 690k | 1.6M | 2.59M | 2.26M |
| Total Equity | 10.97M | 16.79M | 28.37M | 23.96M | 16.73M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -6.76M | -3.39M | -5.16M | -3.3M | -14.28M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.53M | 10.06M | 18.2M | 210k | 6.72M |
| Market Cap | 37.72M |
| Price to Earnings Ratio | -2.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.33 |
| Price to Book Ratio | 2.25 |
| Dividend Yield | - |
| Shares Outstanding | 179.63M |
| Average Volume (1 week) | 124.97k |
| Average Volume (1 Month) | 160.28k |
| 52 Week Change | 16.67% |
| 52 Week High | 0.23 |
| 52 Week Low | 0.105 |
| Spread (Intraday) | 0.01 (4.76%) |
| Company Name | Cynata Therapeutics Ltd |
| Address |
level 3, 62 lygon street melbourne, victoria 3053 |
| Website | https://www.cynata.com |
| Industry | nonwoven fabrics (2297) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
